University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Talimogene laherparepvec in the treatment of melanoma

Appleton, ES, Turnbull, S, Ralph, C, West, E, Scott, K, Harrington, K, Pandha, H and Melcher, A (2015) Talimogene laherparepvec in the treatment of melanoma EXPERT OPINION ON BIOLOGICAL THERAPY, 15 (10). pp. 1517-1530.

Full text not available from this repository.
Item Type: Article
Divisions : Surrey research (other units)
Authors :
Appleton, ES
Turnbull, S
Ralph, C
West, E
Scott, K
Harrington, K
Melcher, A
Date : 1 January 2015
DOI : 10.1517/14712598.2015.1084280
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Biotechnology & Applied Microbiology, Medicine, Research & Experimental, Research & Experimental Medicine, immunotherapy, metastatic melanoma, oncolytic virotherapy, talimogene laheparepvec, HERPES-SIMPLEX-VIRUS, COLONY-STIMULATING FACTOR, TUMOR-INFILTRATING LYMPHOCYTES, RANDOMIZED PHASE-III, TYPE-1 MUTANT G207, METASTATIC MELANOMA, REPLICATION-COMPETENT, ONCOLYTIC REOVIRUS, IMPROVED SURVIVAL, HEPATOCELLULAR-CARCINOMA
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:37
Last Modified : 24 Jan 2020 19:42

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800